SCHEMBL31559679

SCHEMBL31559679

Cc1nc2cc(Br)ccc2c(=O)n1CC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1E P49674 1/20 0.43
▸ CLK1 P49759 1/20 0.43
▸ CLK2 P49760 1/20 0.43
▸ CLK3 P49761 1/20 0.43
▸ CDK9 P50750 1/20 0.43
▸ CDK5 Q00535 1/20 0.43
▸ DYRK1A Q13627 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43
▸ DYRK2 Q92630 1/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43
▸ DYRK4 Q9NR20 1/20 0.43
▸ DYRK1B Q9Y463 1/20 0.43
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ POLB P06746 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ CACNA2D1 P54289 1/20 0.40
▸ METAP2 P50579 3/20 0.40
▸ TSHR P16473 1/20 0.39
▸ APP P05067 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17678057 0.77 CDK9 (0.47) CSNK1ECLK1CLK2CLK3CDK9
SCHEMBL12933338 0.77 MEN1 (0.51) MEN1KMT2APOLBLMNACACNA2D1
SCHEMBL1161500 0.75 CASP3 (0.43) MEN1KMT2ALMNATSHRHDAC1
SCHEMBL30481322 0.75 CASP3 (0.43) MEN1KMT2ALMNATSHRHDAC1
SCHEMBL18337338 0.74 AADAT (0.45) CSNK1ECLK1CLK2CLK3CDK9
SCHEMBL22101746 0.72 LMNA (0.45) MEN1KMT2APOLBLMNAHDAC1
SCHEMBL8351697 0.71 MEN1 (0.54) MEN1KMT2APOLBCACNA2D1HPGD
SCHEMBL31330522 0.71 CNR1 (0.41) CSNK1ECLK1CLK2CLK3CDK9
SCHEMBL12963478 0.69 MEN1 (0.52) MEN1KMT2APOLBCACNA2D1TSHR
SCHEMBL29154640 0.69 HSD17B10 (0.63) POLBLMNAAPPHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090514-A1 COVALENT SARM1 INHIBITORS NURA BIO, INC. (US) 2025-05-01 — — WO disclosed
Send feedback